Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

China Adds Regs to New IPO Process

publication date: Jan 17, 2014
The China Securities Regulatory Commission (CSRC) has issued additional regulations for conducting IPOs under its new “market-oriented” system. In general, the rules are aimed at protecting investors by insuring that underwriters provide full disclosure of the IPO company’s situation – without discussing information that is not included in the officially reviewed prospectus. Specifically, the additional rules stress the importance of price-earnings ratios: if an IPO’s PE ratio is higher than its already-listed peers, underwriters are required to warn investors. More details....

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital